A Transporter of Ibuprofen is Upregulated in MDCK I Cells under Hyperosmotic Culture Conditions
- 25 July 2016
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 13 (9) , 3119-3129
Abstract
Ibuprofen is a widely used drug. It has been identified as an inhibitor of several transporters, but it is not clear if ibuprofen is a substrate of any transporter itself. In the present work, we have characterized a transporter of ibuprofen, which is upregulated by hyperosmotic culture conditions in Madin–Darby canine kidney I (MDCK I) renal cells. [3H]-Ibuprofen uptake rate was measured in MDCK I cell cultured under normal (300 mOsm) and hyperosmotic (500 mOsm) conditions. Hyperosmotic conditions were obtained by supplementing urea, NaCl, mannitol, or raffinose to culture medium. The effect of increased osmolarity was investigated for different incubation times. [3H]-Ibuprofen uptake in MDCK I cells was upregulated by hyperosmotic culture condition, and was saturable with a Km value of 0.37 ± 0.08 μM and a Vmax of 233.1 ± 17.2 pmol· cm–2· min–1. Racemic [3H]-ibuprofen uptake could be inhibited by (R)-(−)- and (S)-(+)-ibuprofen with IC50 values of 19 μM (Log IC50 1.39 ± 0.34) and 0.47 μM (Log IC50 −0.36 ± 0.41), respectively. Furthermore, the [3H]-ibuprofen uptake rate was increased by decreased extracellular pH but not dependent on Na+ or Cl– ions. The mRNA of Mct1, -2, -4, and -6 as well as Oat1 and -3 were not upregulated by hyperosmolarity. Our findings present strong evidence for the presence of a yet unknown ibuprofen transporter in MDCK I cells. The transporter was upregulated under hyperosmotic culture conditions, and the present study is therefore a starting point for identification of the molecular correlate and potential impact on ibuprofen disposition.Keywords
This publication has 27 references indexed in Scilit:
- Ibuprofen is a non‐competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofenBritish Journal of Pharmacology, 2010
- Interaction of Ibuprofen and Other Structurally Related NSAIDs with the Sodium-Coupled Monocarboxylate Transporter SMCT1 (SLC5A8)Pharmaceutical Research, 2006
- Brain Uptake of Nonsteroidal Anti-Inflammatory Drugs: Ibuprofen, Flurbiprofen, and IndomethacinPharmaceutical Research, 2006
- Polarised transport of monocarboxylic acid type drugs across rat jejunum in vitro: the effect of mucolysis and ATP-depletionInternational Journal of Pharmaceutics, 2003
- H+-linked transport of salicylic acid, an NSAID, in the human trophoblast cell line BeWoAmerican Journal of Physiology-Cell Physiology, 2002
- Interactions of Human Organic Anion Transporters and Human Organic Cation Transporters with Nonsteroidal Anti-Inflammatory DrugsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Stereoselectivity of ibuprofen metabolism and pharmacokinetics following the administration of the racemate to healthy volunteersXenobiotica, 2002
- Clinical Pharmacokinetics of IbuprofenClinical Pharmacokinetics, 1998
- Participation of a Proton-Cotransporter, MCT1, in the Intestinal Transport of Monocarboxylic AcidsBiochemical and Biophysical Research Communications, 1995
- Stereoselective plasma protein binding of ibuprofen enantiomersEuropean Journal of Clinical Pharmacology, 1989